All published articles of this journal are available on ScienceDirect.
Alternating Hemiplegia of Childhood and Developmental Delay: A Longitudinal Pediatric Neurogenetic Case Report
Abstract
Background
Alternating hemiplegia of childhood (AHC) is a rare neurodevelopmental disorder most commonly caused by pathogenic variants in ATP1A3. It is characterized by recurrent episodes of alternating hemiplegia, paroxysmal neurological manifestations, developmental delay, and epilepsy. Access to molecular diagnosis remains limited in many low- and middle-income countries, contributing to delayed recognition and management.
Case Presentation
This case report describes a female patient with paroxysmal alternating hemiplegic episodes, developmental delay, and epilepsy. Hemiplegic events were characterized by alternating laterality and remission during sleep at 2 years and 10 months of age. Neuroimaging was largely unremarkable, including a structurally normal brain CT at 14 years of age, without evidence of vascular or progressive structural pathology. Genetic testing identified a heterozygous pathogenic variant in ATP1A3 (c.2839G>A; p.Gly947Arg), confirming the diagnosis of ATP1A3-related AHC. An additional CDKL5 c.2156C>T variant of uncertain significance was detected but was not clinically contributory based on phenotype correlation. Multidisciplinary follow-up showed partial response of hemiplegic episodes to flunarizine and preserved cardiac structure and function.
Conclusion
This case reinforces the clinical and genetic heterogeneity of ATP1A3-related alternating hemiplegia of childhood and highlights the importance of molecular confirmation for accurate diagnosis and management. In resource-limited settings, delayed access to genomic testing may prolong the diagnostic odyssey. Strengthening neurogenetic diagnostic capacity in Latin America is essential to improve early recognition, guide precision-based treatment strategies, and reduce healthcare inequities for patients with rare neurodevelopmental disorders.

